The Sleep Apnea Cardiovascular Endpoints (SAVE) study found that nightly CPAP treatment did not reduce cardiovascular risk in patients with OSA. However, treatment improved well-being and quality of life for the participants.
A new study predicts that heart failure will more than double by 2040 and triple by 2060, with the majority of patients being elderly individuals. The study, which analyzed data from 5706 randomly selected elderly participants, found that the prevalence of heart failure increases with age and is higher in men than women.
The CHART-1 trial, a large-scale cardiovascular study, investigated the use of bone-marrow stem cells to treat congestive heart failure. Although findings were neutral in the overall patient population, an exploratory analysis identified a sub-group that may benefit from cardiopoietic cell therapy.
Research presented at ESC Congress 2016 found that sudden cardiac death in patients with hypertrophic cardiomyopathy occurs relatively rarely during sport activity, but more often at rest and sometimes during sleep. Better strategies aimed at detecting the disease are needed to prevent deaths.
A new study found that iPads are as effective as sedatives in reducing child anxiety before surgery. The use of tablets also improved parental satisfaction and the quality of anaesthesia induction. Researchers concluded that non-pharmacologic tools like iPads can reduce perioperative stress without sedative effects.
A global experiment by researchers found that adding multiple nutrients leads to reduced grassland diversity due to increased competition among species. This study provides evidence that human influence on nutrient cycles is driving environmental conditions beyond planetary boundaries, threatening irreplaceable biodiversity.
A Mediterranean diet is associated with a reduced risk of death in patients with a history of cardiovascular disease. The study found that higher adherence to the Mediterranean diet was linked to a 37% lower risk of death from any cause.
The NIPPON study found that shorter dual antiplatelet therapy (DAPT) is comparable to longer DAPT in terms of net adverse clinical and cerebrovascular events. A combination of short DAPT and a newer DES with bioabsorbable coating may minimize thrombotic events and bleeding complications.
Research found significant disparities in public access defibrillation program implementation across France, leading to uneven survival rates. Basic life support education was strongly correlated with improved outcomes.
The DANISH trial suggests that ICDs should not be routinely implanted in all patients with systolic heart failure, particularly those with non-ischemic aetiology. However, younger patients may have a survival benefit with ICD implantation.
The ANTARCTIC trial found that elderly patients who underwent coronary stenting did not experience improved outcomes with platelet function testing compared to standard, unmonitored approach. Monitoring led to treatment adjustments in nearly half of the patients, yet it didn't improve ischemic or safety outcomes.
A phase II-a randomized trial showed that intravenously administered mesenchymal stem cells resulted in improved health status and functional capacity in patients with chronic non-ischemic cardiomyopathy, but no significant cardiac structural or functional improvements were observed.
A new trial found that remote monitoring of implantable cardiac devices did not reduce mortality or hospitalizations in heart failure patients. Despite widespread adoption, the study suggests that routine use of remote monitoring may not be necessary.
A study of nearly 15,000 heart failure patients in the UK found that up to 80% were not receiving recommended treatments, leading to high rates of hospitalizations and deaths. Patients who received treatment were more likely to be prescribed at target doses, highlighting the need for improved adherence to guideline-recommended therapies.
A recent study published at ESC Congress 2016 found that heart failure patients have a 2% increased risk of dying with each hospital admission. The research, which included over 450,000 patients from the UK, also showed that hospital admissions for patients with heart failure are projected to rise by 50% over the next 25 years.
A study presented at ESC Congress 2016 found that nebivolol treatment prevented anthracycline-induced cardiotoxicity in breast cancer patients. New echocardiographic techniques revealed significant alterations in heart function after chemotherapy, but no changes were noted in the nebivolol-treated group.
A recent study found that the UK spends at least £1.1 billion on asthma care each year, resulting in approximately 1000 deaths and 270 hospital admissions daily due to severe attacks. The majority of these fatalities are preventable with proper basic care.
A nationwide Danish registry study has found that patients with an implantable cardioverter defibrillator (ICD) are at a higher risk of motor vehicle accidents compared to age- and gender-matched controls. The study included 4874 ICD patients and a control group of 9748 subjects, and found a 51% increased risk of motor vehicle accident...
Researchers at the University of Edinburgh have developed a way to detect alpha-synuclein, a protein linked to Parkinson's disease, in spinal fluid samples. The new test shows promise in identifying patients with Parkinson's and Lewy body dementia in early stages.
The MORE-CARE trial found that remote monitoring of cardiac devices did not improve hard clinical outcomes, but showed cost savings and reduced in-office visits, with a 41% reduction in healthcare resource utilization